These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


630 related items for PubMed ID: 12085358

  • 21. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
    Velati C, Marlianici E, Rigamonti D, Barillari G, Chiavilli F, Fugiani P, Garozzo G, Lancieri M, Rinaldi S, Testa D, Sampietro M, Tavazzi D, Delbini P, Fargion S, Fiorelli G.
    Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.
    N Engl J Med; 2005 Apr 28; 352(17):1769-78. PubMed ID: 15858186
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Significance of H63D homozygosity in a Basque population with hemochromatosis.
    Castiella A, Zapata E, de Juan MD, Otazua P, Fernandez J, Zubiaurre L, Arriola JA, Gipuzkoa Hemochromatosis Group.
    J Gastroenterol Hepatol; 2010 Jul 28; 25(7):1295-8. PubMed ID: 20594259
    [Abstract] [Full Text] [Related]

  • 29. HFE haemochromatosis gene mutations in liver transplant patients.
    Halme L, Heliö T, Mäkinen J, Höckerstedt K, Färkkilä M, Piippo K, Krusius T, Kontula K.
    Scand J Gastroenterol; 2001 Aug 28; 36(8):881-5. PubMed ID: 11495086
    [Abstract] [Full Text] [Related]

  • 30. Screening for iron overload in the Turkish population.
    Barut G, Balci H, Bozdayi M, Hatemi I, Ozcelik D, Senturk H.
    Dig Dis; 2003 Aug 28; 21(3):279-85. PubMed ID: 14571105
    [Abstract] [Full Text] [Related]

  • 31. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.
    Hellerbrand C, Pöppl A, Hartmann A, Schölmerich J, Lock G.
    Clin Gastroenterol Hepatol; 2003 Jul 28; 1(4):279-84. PubMed ID: 15017669
    [Abstract] [Full Text] [Related]

  • 32. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
    Nelson JE, Brunt EM, Kowdley KV, Nonalcoholic Steatohepatitis Clinical Research Network.
    Hepatology; 2012 Nov 28; 56(5):1730-40. PubMed ID: 22611049
    [Abstract] [Full Text] [Related]

  • 33. Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis.
    Deguti MM, Sipahi AM, Gayotto LC, Palácios SA, Bittencourt PL, Goldberg AC, Laudanna AA, Carrilho FJ, Cançado EL.
    Braz J Med Biol Res; 2003 Jun 28; 36(6):739-45. PubMed ID: 12792703
    [Abstract] [Full Text] [Related]

  • 34. Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy.
    Cassanelli S, Pignatti E, Montosi G, Garuti C, Mariano M, Campioli D, Carbonieri A, Baldini E, Pietrangelo A.
    J Hepatol; 2001 Apr 28; 34(4):523-8. PubMed ID: 11394651
    [Abstract] [Full Text] [Related]

  • 35. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Bugianesi E, Manzini P, D'Antico S, Vanni E, Longo F, Leone N, Massarenti P, Piga A, Marchesini G, Rizzetto M.
    Hepatology; 2004 Jan 28; 39(1):179-87. PubMed ID: 14752836
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y.
    Wallace DF, Walker AP, Pietrangelo A, Clare M, Bomford AB, Dixon JL, Powell LW, Subramaniam VN, Dooley JS.
    J Hepatol; 2002 Apr 28; 36(4):474-9. PubMed ID: 11943417
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clinical characteristics of HFE C282Y/H63D compound heterozygotes identified in a specialty practice: key differences from HFE C282Y homozygotes.
    Singal M, Mahmoud A, Phatak PD.
    Expert Rev Hematol; 2024 Apr 28; 17(4-5):145-152. PubMed ID: 38551816
    [Abstract] [Full Text] [Related]

  • 40. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
    Skowron F, Bérard F, Grézard P, Wolf F, Morel Y, Perrot H.
    Ann Dermatol Venereol; 2001 May 28; 128(5):600-4. PubMed ID: 11427792
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 32.